​

Theravance Biopharma Ownership | Who Owns Theravance Biopharma?

OverviewForecastRevenueFinancialsChartTranscripts

Theravance Biopharma Ownership Summary

Theravance Biopharma is owned by 93.04% institutional investors, 4.74% insiders, and 2.23% retail investors. Madison avenue partners, lp is the largest institutional shareholder, holding 18.90% of TBPH shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.57% of its assets in Theravance Biopharma shares.

TBPH Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockTheravance Biopharma93.04%4.74%2.23%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Madison avenue partners, lp9.51M18.90%$154.37M
Weiss asset management lp7.46M14.82%$121.03M
Newtyn management4.84M9.62%$78.58M
Blackrock funding, inc. /de4.30M8.54%$69.73M
Blackrock3.78M7.83%$32.06M
Irenic capital management lp2.76M5.50%$40.31M
Vanguard group2.37M4.69%$44.29M
State street1.30M2.58%$21.06M
Acadian asset management1.28M2.54%$20.71M
Two sigma investments, lp1.26M2.50%$20.43M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Newtyn management4.84M8.40%$78.58M
Madison avenue partners, lp9.51M6.71%$154.37M
Irenic capital management lp2.76M4.22%$40.31M
Weiss asset management lp7.46M2.05%$121.03M
Rangeley capital103.00K1.62%$1.67M
Jackson creek investment advisors118.56K0.57%$1.92M
Oasis management583.49K0.55%$9.47M
Cannon global investment management16.05K0.51%$260.44K
Camber capital management lp450.00K0.47%$4.96M
Militia capital partners, lp54.20K0.37%$791.32K

Top Buyers

HolderShares% AssetsChange
Two sigma investments, lp1.26M0.02%721.16K
Newtyn management4.84M8.40%541.63K
Susquehanna group, llp341.58K0.00%319.68K
Vanguard fiduciary trust262.07K0.00%262.07K
683 capital management250.00K0.21%250.00K

Top Sellers

HolderShares% AssetsChange
Baupost group llc/ma---4.20M
Pictet asset management sa---684.89K
Arrowstreet capital, limited partnership327.55K0.00%-635.71K
Camber capital management lp450.00K0.47%-550.00K
Blackrock3.78M0.00%-428.18K

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust262.07K0.00%262.07K$4.25M
683 capital management250.00K0.21%250.00K$4.06M
Algert global199.71K0.05%199.71K$2.92M
Caption management163.70K0.02%163.70K$2.66M
Renaissance127.92K0.00%127.92K$2.08M

Sold Out

HolderChange
Sbi securities-2.00
True wealth design-2.00
Capital performance advisors llp-5.00
Srs capital advisors-6.00
Wealthspire advisors-12.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20261720.58%46,814,907-5.60%930.97%97-2.02%45-4.26%
Dec 31, 202588-47.31%16,063,224-66.80%310.34%45-47.67%29-27.50%
Sep 30, 202570-48.53%10,629,292-77.11%210.24%37-52.56%14-56.25%
Jun 30, 20251352.27%46,426,0143.43%931.15%7732.76%32-31.91%
Mar 31, 20251333.10%44,910,1350.05%901.08%59-10.61%4845.45%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.32M2.57%-
Vanguard US Total Market Shares ETF1.07M2.15%-
iShares Russell 2000 ETF901.94K1.75%7.61K
Pictet Biopharmaceutical Mother652.30K1.32%-349.81K
Vanguard Institutional Extnd Mkt Idx Tr416.16K0.81%2.19K
Fidelity Small Cap Index370.11K0.72%2.89K
Invesco Biotechnology & Genome ETF368.70K0.72%-
iShares Biotechnology ETF353.17K0.69%6.88K
iShares Russell 2000 Value ETF336.22K0.67%-
State St Russell Sm/Mid Cp® Indx NL Cl C330.21K0.66%958.00

Recent Insider Transactions

DateNameRoleActivityValue
Mar 16, 2026Farnum Rhonda SVP, COMM & MEDICAL AFFAIRSSell$108.07K
Mar 16, 2026Farnum Rhonda SVP, COMM & MEDICAL AFFAIRSSell$108.09K
Mar 16, 2026Farnum Rhonda SVP, COMM & MEDICAL AFFAIRSSell$217.48K
Dec 03, 2025Farnum Rhonda SVP, COMM & MEDICAL AFFAIRSSell$145.63K
Dec 03, 2025Farnum Rhonda SVP, COMM & MEDICAL AFFAIRSSell$145.62K

Insider Transactions Trends

DateBuySell
2026 Q2--
2026 Q1-3
2025 Q4-11
2025 Q3-3
2025 Q2-2

TBPH Ownership FAQ

Who Owns Theravance Biopharma?

Theravance Biopharma shareholders are primarily institutional investors at 93.04%, followed by 4.74% insiders and 2.22% retail investors. The average institutional ownership in Theravance Biopharma's industry, Biotech Stocks , is 35.75%, which Theravance Biopharma exceeds.

Who owns the most shares of Theravance Biopharma?

Theravance Biopharma’s largest shareholders are Madison avenue partners, lp (9.51M shares, 18.90%), Weiss asset management lp (7.46M shares, 14.82%), and Newtyn management (4.84M shares, 9.62%). Together, they hold 43.34% of Theravance Biopharma’s total shares outstanding.

Does Blackrock own Theravance Biopharma?

Yes, BlackRock owns 7.83% of Theravance Biopharma, totaling 3.78M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 32.06M$. In the last quarter, BlackRock decreased its holdings by -428K shares, a -10.17% change.

Who is Theravance Biopharma’s biggest shareholder by percentage of total assets invested?

Newtyn management is Theravance Biopharma’s biggest shareholder by percentage of total assets invested, with 8.40% of its assets in 4.84M Theravance Biopharma shares, valued at 78.58M$.

Who is the top mutual fund holder of Theravance Biopharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Theravance Biopharma shares, with 2.57% of its total shares outstanding invested in 1.32M Theravance Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools